Prof. Megherbi of CMINDS recently received recognition from International Research Partnership and Collaboration in big data analytics and its application in the life sciences, personalized and translational medicine. The national and international collaborative research findings, related to comparison of RNA-seq and microarray data from large samples treated with diverse toxic drugs that highlights a dependency of cross-platform concordance on treatment effect, were published in an article titled “The concordance between RNA-seq and microarray data depends on chemical treatment and transcript abundance
”, which recently appeared in Nature Biotechnology
. Ultimately, one of the broader impacts of these studies and research findings will enable RNA-seq to be applied more broadly in analyzing large cohorts for discovery research and clinical use.